Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (2077)	4/16/2004 1:16:21 PM
From: Icebrg	Read Replies (1) \| Respond to of 3044

Ian I am not at all into trading. I believe that an expansion of the use of Velcade to treat earlier stage melanoma and its possible use to treat some NHL-variants will drive the share price over time. As for solid tumors there are three NSCLC-related abstracts - an indication where Millennium have said that they will push forward. I see the drug as having a good upside with a downside at least partially "protected" by the potential use of the drug in NHL. Erik